title: [Medical treatment after implantation of intracoronary stents].
abstract: RATIONALE FOR ANTITHROMBOSIS THERAPY: Introducing a foreign body into the coronaries raises the risk of thrombosis in the acute phase and for the 4 following weeks. The objective of antithrombotic therapy is to inhibit platelet adhesion and aggregation or to induce hypocoagulability. AT IMPLANTATION: High-dose heparin is given in a bolus following pretreatment with aspirin. ASPIRIN-TICLOPIDINE COMBINATION: The risk of subacute thrombosis is low, about 1%, and the rate of vascular complications is minimal. Treatment is simple and compatible with short hospitalization.
authors.affiliation: Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson.
authors.forename: C
authors.initials: C
authors.lastname: Caussin
authors.forename: P
authors.initials: P
authors.lastname: Guyon
authors.forename: M L
authors.initials: ML
authors.lastname: Bourachot
authors.forename: S
authors.initials: S
authors.lastname: Elhadad
authors.forename: B
authors.initials: B
authors.lastname: Lancelin
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D011182:Postoperative Care; D015607:Stents / Q000009:adverse effects*; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants